Navigation Links
Bionovo Announces Publication Describing Potential Estrogen Receptor Modulating Drugs for Treating Menopausal Conditions
Date:10/21/2010

EMERYVILLE, Calif., Oct. 21 /PRNewswire/ -- Bionovo, Inc. (Nasdaq: BNVI) today announced the publication of a review of results from studies discussing new classes of estrogen receptor modulating drugs with distinct mechanism for pharmacological effect. The review is published in the most recent edition of Current Opinion in Pharmacology. The article is entitled, "Regulation of Specific Target Genes and Biological Responses by Estrogen Receptor Subtype Agonists" and is available at: http://www.bionovo.com/investors/publications. This review outlines Bionovo's platform of estrogen receptor modulators for conditions associated with menopause, such as hot flashes, menopausal obesity and metabolic syndrome.

Isaac Cohen, O.M.D., Bionovo's Chairman and Chief Executive Officer, commented, "Bionovo's platform for the discovery of unique drugs for women's health and cancer is described in this review. We now know we can selectively regulate estrogen receptors for specific indications that have a better safety profile. This opens the door for new treatments for many afflictions women encounter after menopause. Our drugs are aimed at areas of unmet needs, such as post menopausal obesity, metabolic syndrome and cancer prevention."

"Estrogen receptors are associated with many diseases and disorders that women encounter after menopause. These include breast cancer, cardiovascular diseases, obesity, diabetes, and Alzheimer's disease. When designing drugs for these disorders, selectivity and specificity are critical aspects to ensure safety and efficacy. Estrogen receptors have multiple functions in numerous tissues, and when stimulated non-selectively, as current estrogens used for menopausal symptoms do, the results are mixed with both benefits and risks," said Dr. Dale Leitman, M.D., Ph.D. from University of Califor
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
2. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
4. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
5. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
7. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
8. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
9. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
11. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... YORK , Sept. 2, 2015 ... is an X-linked disease, which generally affects the ... degeneration and weakness. The disease is caused due ... in the lack of production of dystrophin (a ... individuals. The lack of dystrophin weakens muscle function, ...
(Date:9/2/2015)... NEW YORK , Sept. 2, 2015 ... leukemia is a malignant condition characterized by increased production ... first affects B-lymphocytes and then it can spread to ... mostly at later stages because of the slow buildup ... disease, the malignancy spreads to the spleen, liver, and ...
(Date:9/2/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/l8z67c/pharmaceutical ) has ... China (Basel, Switzerland - November 26-27, 2015)" conference to ... detailed overview of the key areas of pharmaceutical regulatory affairs ... , Macau and ... All important aspects of gaining and maintaining a successful Marketing ...
Breaking Medicine Technology:Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 2Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 3Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2
... , SAN FRANCISCO , May 18 ... demonstrated patients treated with a standard or low dose of ... in how often they were awakened at night by hot ... presented today at the 58th Annual Clinical Meeting of the ...
... NANJING , China, May 18 /PRNewswire-Asia/ -- ... ), a leading pharmaceutical company,specializing in the development, manufacturing, and ... preliminary,unaudited financial results for the quarter ended March 31, ... -- Total revenue was RMB458.7 million (US$67.2 million) for ...
Cached Medicine Technology:New Study Shows ENJUVIA® Significantly Reduced 'Sleep Time' Awakenings Caused by Hot Flashes in Postmenopausal Women 2New Study Shows ENJUVIA® Significantly Reduced 'Sleep Time' Awakenings Caused by Hot Flashes in Postmenopausal Women 3New Study Shows ENJUVIA® Significantly Reduced 'Sleep Time' Awakenings Caused by Hot Flashes in Postmenopausal Women 4New Study Shows ENJUVIA® Significantly Reduced 'Sleep Time' Awakenings Caused by Hot Flashes in Postmenopausal Women 5New Study Shows ENJUVIA® Significantly Reduced 'Sleep Time' Awakenings Caused by Hot Flashes in Postmenopausal Women 6New Study Shows ENJUVIA® Significantly Reduced 'Sleep Time' Awakenings Caused by Hot Flashes in Postmenopausal Women 7Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 2Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 3Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 4Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 5Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 6Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 7Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 8Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 9Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 10Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 11Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 12
(Date:9/3/2015)... ... September 03, 2015 , ... At Renew Man™, we ... with the traditional health care model, where the primary care physician dictates and the ... want to become educated about their health issues and empowered to choose their own ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... About 220,800 new cases of prostate cancer ... seven men will be diagnosed with prostate cancer during their lifetime. While only one man ... of every 10 men by age 65, according to the American Cancer Society. ...
(Date:9/3/2015)... ... September 03, 2015 , ... James Earl Jones will be hosting ... this episode, James Earl Jones will introduce a segment that discusses why it is ... how workplace wellness can be fostered in any working environment. , Employers are out ...
(Date:9/3/2015)... FLORIDA (PRWEB) , ... September 03, 2015 , ... ... of the highest-regarded health professionals out there. His perspective on internal medicine keeps patients ... stay happy and healthy is important regardless of the season, but even more so ...
(Date:9/3/2015)... COLO (PRWEB) , ... September 03, 2015 , ... Fashion ... the very beginning of the most recent episode of the hit ABC series ... didn’t fit the image of her industry. She provided herself with the motivation to ...
Breaking Medicine News(10 mins):Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 3Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 3
... from living in two-parent families may actually be due to ... married. A new study finds that children who who ... do as well as those in married households in terms ... studies that show an advantage for children who grow up ...
... , , MONROE, Mich., ... center are joining forces to bring world-renowned cancer services to ... Health System of Toledo, and the Barbara Ann Karmanos Cancer ... will bring innovative, state-of-the-science cancer care to Monroe and the ...
... , Channels Extend Their Pledge for the ... , , LOS ANGELES and NEW YORK, Aug. 31 ... partnership with FC Barcelona and Malaria No More to end malaria deaths through ... campaign during Fox Football Fone-In, Fox Soccer Channel,s weekly call-in ...
... , WALTHAM, Mass., Aug. 31 ... dangerously hot weather conditions, Mobile Sports, Inc. (MSI) today announced ... athletes, parents of athletes, coaches, and athletic trainers the tools ... serious heat-related illnesses. , , ...
... Aug. 31 Mederi Therapeutics Inc. announces the US release ... Secca Therapy is a minimally invasive procedure for a debilitating ... both young and old. Secca therapy delivers radiofrequency (RF) energy ... muscles, producing better bowel control and reducing the symptoms of ...
... ... and Careers Division , ... York (PRWEB) August 31, 2009 -- The education and technology company Pearson today ... of its Professional & Career business., , , , ,Pearson,s Health Science and Careers division ...
Cached Medicine News:Health News:Family stability may be more crucial than 2 parents for child success 2Health News:Family stability may be more crucial than 2 parents for child success 3Health News:Three Health Institutions Join Forces to Bring World-Renowned Cancer Care to Monroe, Michigan 2Health News:Three Health Institutions Join Forces to Bring World-Renowned Cancer Care to Monroe, Michigan 3Health News:Three Health Institutions Join Forces to Bring World-Renowned Cancer Care to Monroe, Michigan 4Health News:Fox Soccer Channel and Fox Sports en Espanol Renew 'Every Goal Saves A Life' Campaign With Malaria No More 2Health News:Fox Soccer Channel and Fox Sports en Espanol Renew 'Every Goal Saves A Life' Campaign With Malaria No More 3Health News:Fox Soccer Channel and Fox Sports en Espanol Renew 'Every Goal Saves A Life' Campaign With Malaria No More 4Health News:New Technology Helps Athletes Prevent Dehydration and Heat-Related Illness 2Health News:Secca(R) Therapy - An Effective and Minimally Invasive Option for Treating Bowel Incontinence - Launched in the US 2Health News:Pearson Announces Leah Jewell as President of Health Science and Careers Division 2Health News:Pearson Announces Leah Jewell as President of Health Science and Careers Division 3
The cemented hip joint prosthesis system....
The uncemented hip joint prosthesis system....
The cemented hip joint prosthesis system....
The Quatroloc primary hip system offers 35 primary stems to fit almost all femurs for primary hip arthroplasty....
Medicine Products: